Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",21806,196,1.02 [0.87-1.20],0.8219152191973977
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23023,253,1.06 [0.92-1.22],0.4143289809411967
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22743,1761,1.05 [0.99-1.10],0.1000610431142593
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23025,553,1.06 [0.97-1.17],0.2179170792804878
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22268,4232,1.04 [1.00-1.08],0.0305606451661272
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22211,4291,1.03 [0.99-1.06],0.1333681152721894
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22737,1427,1.03 [0.97-1.09],0.383536455102059
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,22930,130,1.09 [0.90-1.32],0.3903452819530976
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20218,1303,1.04 [0.98-1.11],0.2289272640847052
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19503,1584,1.04 [0.98-1.10],0.1825975541188824
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,19000,343,1.08 [0.96-1.22],0.2073145000197662
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14974,2738,1.03 [0.98-1.07],0.2589151927659344
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18940,500,1.09 [0.99-1.20],0.0938148062041939
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23006,1696,1.02 [0.97-1.08],0.4044419991903516
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Mycoses,23121,649,1.09 [1.00-1.19],0.0575332859847832
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22226,1244,1.03 [0.96-1.09],0.4461335720602049
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23049,1439,1.03 [0.97-1.09],0.3141826587924698
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21563,253,1.06 [0.92-1.22],0.3932603706766597
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23182,65,1.15 [0.88-1.51],0.31303566800801
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22866,1256,1.03 [0.96-1.10],0.393482766163602
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22882,82,1.18 [0.93-1.51],0.1758445237034008
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23117,143,1.21 [1.01-1.45],0.0436965643209356
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23094,120,1.23 [1.01-1.50],0.0435567957376109
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21487,505,1.17 [1.06-1.29],0.001904773514108
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,21295,313,0.99 [0.87-1.13],0.8908792442335238
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,21447,137,1.12 [0.93-1.35],0.2489786828527772
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23167,52,0.92 [0.67-1.25],0.5806054824741651
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23113,175,1.10 [0.93-1.30],0.2766921410289705
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral warts,22995,57,1.56 [1.18-2.06],0.0015807301148578
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23017,79,0.95 [0.73-1.22],0.6749548827487679
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm,22888,262,0.85 [0.74-0.98],0.0218073296732644
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23099,39,0.83 [0.58-1.20],0.3209050938204533
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23081,42,0.89 [0.63-1.27],0.5320039257603099
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,11039,84,0.85 [0.66-1.09],0.2112993100649646
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22718,1670,1.03 [0.98-1.09],0.2203458927831301
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of meninges,23168,65,1.17 [0.89-1.54],0.261377220627124
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23085,81,1.13 [0.89-1.45],0.320073099263692
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23155,118,0.95 [0.77-1.17],0.6356414544107308
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of ovary,12073,80,1.07 [0.83-1.37],0.6098422912261876
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23142,440,1.02 [0.92-1.14],0.7004434281397038
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Caecum,23147,383,1.01 [0.90-1.14],0.8386138700986415
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23033,88,0.92 [0.72-1.17],0.5122071444698624
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23139,254,1.03 [0.90-1.19],0.6437276449742444
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Rectum,23098,402,0.97 [0.87-1.08],0.588681505810966
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23030,675,1.03 [0.95-1.13],0.4359850730535026
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23124,544,1.09 [0.99-1.19],0.0928403931112754
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Carcinoma in situ of breast,9066,49,0.83 [0.60-1.16],0.2738682700876449
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",9109,66,1.11 [0.84-1.46],0.4613318210511207
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16522,72,1.08 [0.83-1.40],0.578191613124603
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16547,97,0.99 [0.79-1.25],0.9347031552937908
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23124,125,0.81 [0.66-1.00],0.0493935984350185
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Haemangioma, any site",23125,122,0.82 [0.67-1.01],0.0612697929201382
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Leiomyoma of uterus,11802,169,0.98 [0.83-1.17],0.8582739713803949
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Lung cancer and mesothelioma,14653,478,1.00 [0.90-1.10],0.974173929842316
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Lymphoid leukaemia,16523,73,1.07 [0.82-1.38],0.6338505455405861
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16676,226,1.04 [0.90-1.21],0.5857615966378111
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16771,321,0.95 [0.84-1.08],0.4430167790570167
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",9188,103,0.84 [0.67-1.05],0.1274300088655247
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16562,112,1.12 [0.90-1.38],0.3093604690418853
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16595,145,1.11 [0.92-1.34],0.2640781631473353
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16575,125,0.93 [0.76-1.14],0.4660177309879241
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",9173,88,0.94 [0.74-1.20],0.6094170669453312
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16578,128,0.97 [0.79-1.18],0.7395587705243948
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8340,975,0.95 [0.88-1.02],0.1550585918704433
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16590,140,0.94 [0.78-1.14],0.549583789513646
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16542,92,1.21 [0.96-1.51],0.1050566281442918
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16596,146,0.96 [0.80-1.16],0.689868058953613
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanocytic naevi,23034,185,1.06 [0.90-1.25],0.4530706440372853
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanocytic naevi of trunk,23153,79,1.30 [1.02-1.65],0.0348399532211806
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanoma in situ,16502,110,1.11 [0.90-1.37],0.3376181406981653
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16570,120,0.97 [0.79-1.20],0.8046052836707349
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16650,200,0.99 [0.85-1.17],0.9489160777440976
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16776,326,0.88 [0.78-1.00],0.0556031095668606
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16579,129,1.05 [0.86-1.28],0.636075948180564
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Other benign neoplasms of skin,23009,165,0.95 [0.80-1.13],0.5555309534313395
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",17949,1499,0.98 [0.93-1.04],0.5432483860764612
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18033,1583,0.99 [0.94-1.05],0.7789775650221111
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22871,400,0.95 [0.85-1.07],0.4083253043734435
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,20852,165,1.10 [0.92-1.31],0.2881013840728722
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22542,71,1.11 [0.85-1.45],0.433663359369304
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22413,3515,1.04 [1.00-1.08],0.029819893315553
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,21450,73,1.37 [1.06-1.76],0.0145139986662564
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22707,62,0.92 [0.69-1.23],0.5772864723690714
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22668,1981,1.06 [1.01-1.11],0.0233519040697525
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22666,1979,1.06 [1.01-1.11],0.0259105780095678
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,20803,116,0.92 [0.74-1.13],0.4202652434758659
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22814,1437,1.15 [1.08-1.21],5.392940643379255e-06
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22756,111,0.83 [0.67-1.04],0.1039664463433842
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22547,76,0.98 [0.75-1.27],0.8556776387408349
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22548,77,0.97 [0.75-1.25],0.815598475135801
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23001,356,0.80 [0.71-0.90],0.000318599746906
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23049,39,0.82 [0.57-1.18],0.281012904029183
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",22937,292,0.70 [0.61-0.81],5.055131372566528e-07
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21514,137,1.11 [0.92-1.34],0.2909656960100353
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15486,422,1.07 [0.96-1.19],0.2451085717855855
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21672,103,1.07 [0.86-1.33],0.5579628395868778
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21682,113,1.10 [0.89-1.36],0.3765726853387285
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,15135,71,1.02 [0.78-1.33],0.8896059418610988
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21539,65,0.91 [0.69-1.21],0.5279198834138583
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20743,317,0.92 [0.81-1.05],0.220451279364768
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22381,956,0.96 [0.90-1.04],0.3286996698425912
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,21908,483,0.95 [0.86-1.06],0.3834123079881907
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21643,218,1.10 [0.95-1.28],0.2102525549806596
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,22893,1419,1.09 [1.03-1.16],0.0038539193945957
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19498,1374,1.10 [1.03-1.17],0.0024163278875472
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",15155,91,0.89 [0.70-1.13],0.3408797311294048
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20871,100,1.12 [0.90-1.40],0.3173862387353052
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15429,365,1.00 [0.89-1.13],0.9716283478212724
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,15121,57,1.12 [0.83-1.50],0.4498647851856331
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19676,4612,1.04 [1.01-1.07],0.0221044470775709
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15332,268,1.01 [0.88-1.16],0.8881242218266163
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15780,716,1.02 [0.94-1.11],0.6119762827966767
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23124,373,1.09 [0.97-1.22],0.1474436091662532
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,22913,162,1.00 [0.84-1.19],0.984668336573898
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,15221,157,1.00 [0.84-1.20],0.9940307614799048
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",15147,83,1.02 [0.79-1.30],0.8986288867905547
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22536,1765,1.02 [0.97-1.08],0.4870167650410967
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15456,392,1.11 [0.99-1.25],0.0689915200524971
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15496,432,1.01 [0.91-1.13],0.8010952286870053
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15938,874,1.06 [0.99-1.15],0.108812868947362
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,15240,176,0.90 [0.76-1.07],0.22438434354265
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,22903,152,0.99 [0.82-1.19],0.8881182978226121
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15970,906,1.03 [0.96-1.11],0.386704514196293
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15723,659,1.01 [0.93-1.11],0.7590040516130284
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20505,79,1.00 [0.77-1.28],0.9769721662011004
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21521,6457,1.03 [1.00-1.06],0.0378896876295944
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20831,60,1.01 [0.76-1.35],0.942748458204733
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20821,50,0.87 [0.63-1.20],0.3815101775480435
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22996,1915,0.98 [0.93-1.03],0.3942690070038491
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22994,1913,0.98 [0.93-1.03],0.4400826874311707
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20837,66,1.07 [0.81-1.40],0.6504257492778032
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,22823,1130,1.04 [0.97-1.11],0.2694766933727138
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17324,2260,1.03 [0.98-1.08],0.2533176180237846
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23166,318,1.04 [0.92-1.18],0.551080506604199
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21557,132,1.07 [0.88-1.30],0.5229023783107329
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21810,117,0.93 [0.75-1.15],0.509642765670944
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21860,167,1.21 [1.02-1.43],0.0284365816208002
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",15261,197,1.08 [0.92-1.27],0.3206239803013119
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20374,181,1.01 [0.85-1.19],0.931719434953348
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2483,101,0.99 [0.78-1.25],0.929173584583036
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2648,308,1.00 [0.88-1.14],0.971817797093982
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20278,85,1.18 [0.94-1.50],0.1609421185574696
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2456,77,0.86 [0.66-1.14],0.2962472180249353
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22331,2138,1.06 [1.01-1.11],0.0279691537394579
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22050,625,0.90 [0.82-0.99],0.0240135488905883
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,20877,451,1.06 [0.95-1.17],0.3151782264286841
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16193,1129,1.06 [0.99-1.13],0.1111660521652685
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23045,309,0.91 [0.80-1.03],0.1331070013071666
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21668,270,0.88 [0.77-1.01],0.080066953936024
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Angina pectoris,20018,1581,1.01 [0.95-1.07],0.7467261920186374
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21774,376,0.88 [0.79-0.99],0.0378199079014015
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21488,90,1.12 [0.89-1.42],0.3221516203844559
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21689,291,1.09 [0.96-1.25],0.1710913638097673
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11717,2852,0.97 [0.93-1.01],0.1142977492073624
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,AV-block,17598,677,1.05 [0.96-1.14],0.2872142899711697
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23098,575,0.92 [0.83-1.01],0.0723202624300655
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,9130,265,1.20 [1.05-1.37],0.0089005242199172
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,17126,205,0.80 [0.68-0.94],0.0068392620769667
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",17033,112,0.92 [0.74-1.14],0.4611473911018965
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23176,83,1.16 [0.91-1.48],0.2330892982643933
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Conduction disorders,18486,1565,1.02 [0.97-1.08],0.4049904480750256
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21172,2759,1.00 [0.96-1.04],0.9203384417355412
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18581,8918,1.01 [0.99-1.04],0.353092631312588
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21602,340,0.92 [0.82-1.05],0.20748327038871
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Endocarditis,17024,103,1.24 [1.00-1.53],0.0534250184761
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22886,1671,1.06 [1.00-1.12],0.0461642124011124
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertension,19821,7933,1.02 [1.00-1.05],0.0658027478710131
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19840,7952,1.02 [1.00-1.05],0.0744062332574527
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23009,99,0.95 [0.76-1.20],0.6830426519814433
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12155,267,1.07 [0.93-1.23],0.3299969781114635
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12097,209,1.28 [1.10-1.49],0.0015944927277264
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypotension,22996,1648,1.04 [0.99-1.10],0.1197790184565273
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,21878,148,0.88 [0.73-1.06],0.1803169022934534
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21348,2911,1.00 [0.96-1.04],0.9271216147132232
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22662,806,1.05 [0.97-1.14],0.1950328669790185
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17453,532,0.99 [0.89-1.09],0.7943671710890776
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22483,1061,1.02 [0.95-1.09],0.6456039573769711
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19350,913,1.03 [0.96-1.11],0.3674312227150439
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23051,186,1.21 [1.04-1.43],0.0168866170649388
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23136,410,0.98 [0.88-1.09],0.6967545229806618
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,21331,69,0.96 [0.73-1.26],0.759606138317336
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other aneurysm,21503,105,1.06 [0.85-1.31],0.6231885162297316
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,17522,601,1.05 [0.96-1.15],0.3134070832681346
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21537,139,1.10 [0.92-1.33],0.2988449079204514
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21732,334,0.97 [0.86-1.10],0.6439062374001887
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,17144,223,0.98 [0.84-1.14],0.7917592619193349
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,21382,120,1.07 [0.87-1.32],0.5000235555664228
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21308,46,1.11 [0.80-1.54],0.5265858379920565
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,21114,91,0.88 [0.70-1.13],0.3195611412885026
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21442,180,1.03 [0.87-1.22],0.7143239748485315
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18388,1467,0.96 [0.91-1.02],0.2396478608312882
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21411,63,0.94 [0.71-1.25],0.673905517100755
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22134,736,1.02 [0.94-1.10],0.6840553823434052
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22404,536,1.06 [0.96-1.17],0.2256798152260608
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22002,979,1.00 [0.93-1.07],0.942783147762792
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9285,420,0.94 [0.84-1.05],0.2587554963940036
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21958,596,1.04 [0.95-1.14],0.4163547526608171
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21689,427,0.92 [0.82-1.02],0.1186386892192295
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22475,607,1.01 [0.92-1.11],0.8550594711857856
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23079,981,1.00 [0.93-1.07],0.9355566217117562
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17440,519,1.04 [0.94-1.15],0.4455642411167945
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22397,529,1.07 [0.97-1.18],0.1867998587195446
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21288,265,0.97 [0.85-1.12],0.6941491671067102
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22648,918,1.03 [0.96-1.11],0.4005032229807812
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22633,958,1.03 [0.96-1.11],0.4073533737110443
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,21845,63,0.94 [0.71-1.25],0.6690951013597461
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21504,106,0.85 [0.68-1.06],0.142590161665618
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22182,326,1.07 [0.94-1.21],0.2962348720553655
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21758,336,1.08 [0.96-1.22],0.2138532758710471
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Varicose veins,21781,519,1.06 [0.96-1.17],0.2483955339823463
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,21419,125,0.90 [0.73-1.10],0.2978743815229467
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22902,957,0.96 [0.90-1.04],0.3309360184200382
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23098,334,1.08 [0.96-1.22],0.2131618683128509
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19802,1379,1.05 [0.99-1.12],0.1116262559258384
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Any mental disorder,22641,4218,1.03 [1.00-1.07],0.0768471417949964
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23070,393,1.07 [0.96-1.20],0.2390632887052203
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19869,1446,1.10 [1.03-1.16],0.0023122142155097
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18510,87,1.06 [0.83-1.35],0.6327359830116089
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Smoking dependency,22664,1181,1.03 [0.97-1.10],0.3085506981801801
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19876,1453,1.03 [0.97-1.10],0.2660314212093513
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Vascular dementia,22280,231,0.87 [0.75-1.02],0.078255065189214
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Alzheimer disease,23178,592,0.99 [0.91-1.09],0.8993275683703841
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",14200,110,1.05 [0.85-1.30],0.6599909405752744
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Bell's palsy,21320,86,1.08 [0.85-1.37],0.5428084565751907
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21725,491,1.04 [0.94-1.15],0.4517077553942992
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Cerebral cysts,22730,250,1.06 [0.92-1.22],0.4547767044586486
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23103,412,0.93 [0.83-1.04],0.2257222568030331
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,22322,76,1.09 [0.84-1.40],0.5182152062058633
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23160,69,0.85 [0.65-1.13],0.2636376368183121
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22567,87,1.09 [0.85-1.38],0.4991160541142073
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Epilepsy,21660,307,0.98 [0.86-1.11],0.7438603793804828
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22711,1358,1.02 [0.96-1.08],0.5539135540863361
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23127,929,0.99 [0.92-1.06],0.7643723490046141
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22517,3460,0.98 [0.94-1.02],0.3432815308420023
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,22795,54,1.07 [0.79-1.45],0.654722505265112
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Hemiplegia,23028,337,0.99 [0.88-1.12],0.9305977435230331
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Hydrocephalus,22553,73,0.93 [0.71-1.21],0.5936297947844218
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23166,72,1.23 [0.95-1.59],0.1190126130724215
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21299,65,0.92 [0.70-1.22],0.584714424089753
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21305,71,0.92 [0.70-1.21],0.5677825634310749
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Memory loss,22027,140,0.93 [0.77-1.13],0.4758563982092917
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Migraine,21636,283,0.99 [0.86-1.13],0.860945058663178
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23130,259,0.98 [0.86-1.13],0.8315772711068427
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Motor neuron disease,14285,172,1.00 [0.84-1.19],0.9821420887532
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23048,58,0.95 [0.71-1.28],0.7504289458012265
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22464,1230,1.03 [0.97-1.10],0.3596285902847118
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Neurological diseases,21687,4366,1.01 [0.98-1.05],0.562442620627748
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22573,327,0.96 [0.85-1.09],0.5466437852920976
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21663,429,1.08 [0.97-1.20],0.1522783211632304
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23098,354,1.04 [0.93-1.17],0.4953156071367349
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17339,979,1.01 [0.94-1.08],0.8213824644998322
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22566,86,1.03 [0.81-1.31],0.818215261910513
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22642,162,0.90 [0.75-1.07],0.2377727149405257
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,22433,235,1.03 [0.89-1.19],0.6991588609492418
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21331,97,1.06 [0.85-1.33],0.5940818991964645
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other headache syndromes,21406,53,0.90 [0.66-1.23],0.4967065521588145
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23065,585,1.00 [0.91-1.10],0.980094901718097
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other sleep disorders,21868,515,1.03 [0.94-1.14],0.5042508555155243
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Parkinson's disease,23147,689,0.97 [0.89-1.06],0.4586364736057144
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22526,46,1.21 [0.87-1.66],0.2547620000769689
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23179,107,1.03 [0.83-1.29],0.7559049587480421
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Sleep apnoea,22942,435,1.03 [0.92-1.15],0.5996377927223451
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22806,62,0.93 [0.70-1.24],0.622471432642075
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23167,200,0.98 [0.84-1.15],0.7952382149730765
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21303,69,0.95 [0.72-1.24],0.7002582972548281
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23178,598,0.99 [0.91-1.09],0.8761107835371291
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22218,225,0.87 [0.75-1.02],0.0866048761954474
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22527,155,1.01 [0.84-1.21],0.932067116350404
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22715,564,1.00 [0.91-1.10],0.9349195109244608
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22920,265,0.96 [0.84-1.11],0.5968154504884595
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,21940,68,1.09 [0.83-1.43],0.5244583611033071
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,21909,37,1.33 [0.94-1.90],0.1111010870906418
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23055,73,1.26 [0.97-1.62],0.0804793464661055
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,22862,224,1.00 [0.86-1.17],0.9599633005941012
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2460,78,0.83 [0.63-1.09],0.1884234278995722
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3033,115,0.98 [0.78-1.22],0.8379299323794016
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22478,106,1.19 [0.97-1.48],0.1012215784435655
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22872,1429,1.02 [0.96-1.09],0.4425597539960483
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22762,890,1.01 [0.93-1.09],0.8412897735427158
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22178,306,1.11 [0.97-1.26],0.1174122409738099
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23103,952,0.99 [0.92-1.07],0.8678916133026116
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23173,81,1.37 [1.08-1.74],0.0091107560935935
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23030,879,0.99 [0.92-1.07],0.7633554057816256
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23138,500,0.99 [0.90-1.10],0.898666745282055
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23056,229,1.12 [0.97-1.30],0.1323185523666129
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,21973,101,1.07 [0.86-1.34],0.5453884429400715
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,21979,107,0.96 [0.77-1.20],0.7305803503764678
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,21948,76,1.09 [0.85-1.41],0.4998872012801296
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23039,1008,1.01 [0.94-1.08],0.7790743402587146
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22298,267,1.04 [0.90-1.19],0.6110985359105209
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22222,71,0.80 [0.60-1.05],0.1012858763994128
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22761,123,0.89 [0.73-1.10],0.2832887454921285
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23029,391,1.00 [0.90-1.13],0.939319918744868
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22374,223,0.98 [0.84-1.14],0.7957666066002903
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,22971,144,1.01 [0.84-1.21],0.9371447602506237
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22703,672,1.02 [0.94-1.12],0.5827040163788253
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22534,162,0.94 [0.79-1.13],0.5263616022612706
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20724,3259,1.03 [0.99-1.07],0.1069587240962072
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,22984,346,1.00 [0.88-1.12],0.9577237804612352
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23164,193,1.08 [0.92-1.26],0.36482556879253
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22419,547,0.97 [0.88-1.06],0.4842290249095136
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22728,90,0.91 [0.71-1.15],0.4269450259013725
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23164,72,1.33 [1.03-1.71],0.027347335076327
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22000,128,0.86 [0.70-1.05],0.1480280696355619
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22047,175,0.86 [0.72-1.02],0.0808601547838227
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21610,167,1.13 [0.95-1.34],0.155249841149975
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22214,63,0.93 [0.70-1.24],0.6260319566132568
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21517,74,0.79 [0.61-1.04],0.0922521957549116
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22145,114,0.88 [0.71-1.09],0.2413877345392299
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22327,296,1.10 [0.97-1.25],0.1467234682418633
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22034,162,0.98 [0.82-1.17],0.8430976149261733
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21541,98,1.16 [0.93-1.44],0.1999390034532286
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21578,135,1.03 [0.85-1.24],0.7920956164863806
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20215,2750,1.01 [0.97-1.05],0.6697737625752862
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,21963,91,1.09 [0.87-1.38],0.4545104801739943
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22880,508,1.04 [0.94-1.15],0.4626454708288121
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22453,81,1.07 [0.84-1.37],0.5725132338067465
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22584,212,1.10 [0.95-1.29],0.1999683108869544
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,22959,113,0.98 [0.79-1.21],0.8513875129603834
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23132,138,0.98 [0.81-1.19],0.8663746725034629
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23039,118,1.19 [0.97-1.45],0.0980636950167143
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,22911,65,0.95 [0.72-1.25],0.7028965628844631
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,22914,68,0.93 [0.71-1.23],0.6289846330980242
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23072,1254,1.02 [0.95-1.08],0.6428498564941054
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22769,951,1.04 [0.96-1.11],0.345879843683557
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,21971,153,0.78 [0.65-0.94],0.0097412131752741
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,21908,90,1.09 [0.86-1.37],0.4864112668005856
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,22986,66,1.01 [0.77-1.33],0.9475067737600396
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23107,187,0.96 [0.81-1.13],0.5977756526679927
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,22984,64,0.94 [0.71-1.25],0.6703446863394729
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,All influenza,20485,159,1.06 [0.89-1.27],0.4851837929403766
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20482,156,1.09 [0.91-1.30],0.3560457578434344
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),14278,103,1.25 [1.00-1.55],0.0452879072831205
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23069,240,1.02 [0.88-1.17],0.8340830513675973
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15503,1718,1.08 [1.02-1.14],0.0048432776523795
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15871,1696,1.08 [1.02-1.14],0.0079319405513626
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22655,180,1.07 [0.91-1.27],0.4112534278411721
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",20431,105,1.09 [0.87-1.35],0.454209332275506
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Bronchiectasis,19425,519,1.16 [1.05-1.28],0.0025208668273213
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",18981,75,1.42 [1.11-1.81],0.0051306930326565
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22044,3138,1.07 [1.03-1.11],0.0013781042491315
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",21955,72,1.10 [0.85-1.43],0.478425757299286
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22018,135,1.06 [0.87-1.28],0.5558123458689044
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22890,1637,1.05 [0.99-1.11],0.0756051972193445
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,21960,77,1.02 [0.79-1.31],0.8896794687297218
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21018,6116,1.05 [1.02-1.08],0.0005366511407896
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22217,334,1.04 [0.92-1.18],0.4939690430682788
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Early onset COPD,21361,108,0.98 [0.79-1.22],0.8565915366470649
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Emphysema,19346,440,1.13 [1.02-1.26],0.0176241067068479
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21873,456,1.08 [0.98-1.20],0.1357108196030878
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22925,2599,1.05 [1.01-1.10],0.0200551564366424
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,21918,501,1.09 [0.99-1.21],0.0783936316930384
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Later onset COPD,22660,1529,1.06 [1.00-1.12],0.0573215360993206
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23163,500,1.09 [0.99-1.21],0.0798965395845751
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Nasal polyp,21979,96,0.98 [0.78-1.24],0.8765898824745504
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22893,1303,1.06 [0.99-1.12],0.0798774007317625
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,22884,2697,1.04 [0.99-1.08],0.0991456844647638
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22635,752,1.04 [0.96-1.13],0.3017868045496309
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other pleural conditions,20256,69,0.97 [0.74-1.27],0.8295280503624871
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23056,600,1.11 [1.01-1.21],0.0259826244710916
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23050,1725,1.06 [1.01-1.12],0.0246669160384033
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pleural effusion,21561,1374,1.04 [0.98-1.10],0.2387979549595885
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pleural plaque,20440,253,1.02 [0.89-1.17],0.7938757680750345
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22635,2309,1.05 [1.01-1.10],0.0246973049377452
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23053,390,1.08 [0.97-1.21],0.1688220494673605
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pneumothorax,20357,170,0.87 [0.73-1.04],0.1236168988382936
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pollen allergy,23167,205,1.07 [0.92-1.25],0.3952949316166924
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,22551,95,1.12 [0.89-1.41],0.3301052407784199
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,14245,70,1.28 [0.98-1.66],0.0659167081109405
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22870,1280,1.06 [0.99-1.13],0.0816783033331889
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22125,242,1.02 [0.89-1.18],0.7520822836493065
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Viral pneumonia,20631,305,1.02 [0.90-1.16],0.7833564099748176
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22664,244,0.97 [0.84-1.13],0.7231695947093963
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7389,120,1.09 [0.89-1.34],0.394920631500755
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14680,61,1.14 [0.85-1.51],0.3810615358176747
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23065,125,1.05 [0.86-1.28],0.6511424595048805
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute gastritis,16096,107,1.13 [0.91-1.40],0.2738570602510498
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,21110,197,1.13 [0.97-1.33],0.1190006963035962
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute peritonitis,22685,110,1.15 [0.93-1.42],0.1992497287787405
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22194,65,1.04 [0.79-1.38],0.7605027707335742
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,16500,511,0.97 [0.88-1.08],0.5950496154349982
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21062,149,1.14 [0.96-1.37],0.1434590759824682
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22755,149,1.14 [0.95-1.37],0.1631008409589182
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Cholecystitis,21136,223,0.97 [0.83-1.13],0.6646124798075086
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Cholelithiasis,21970,1057,1.07 [1.00-1.14],0.0664410360507879
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Chronic gastritis,16338,349,1.02 [0.90-1.14],0.8069790054028958
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,20968,55,1.04 [0.77-1.40],0.8232796388955981
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23041,131,1.02 [0.84-1.24],0.8593673836175985
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Coeliac disease,21435,127,1.15 [0.95-1.40],0.1577109330686084
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Collagenous colitis,21430,102,0.94 [0.75-1.17],0.5584896494700018
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23061,159,0.98 [0.82-1.17],0.8414403328485953
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Constipation,22890,2141,1.00 [0.95-1.05],0.9130883161627148
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Crohn disease,21417,89,1.17 [0.93-1.48],0.1915291466735806
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22825,68,1.11 [0.85-1.45],0.4401266902227706
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21409,81,1.20 [0.94-1.53],0.1468347512282961
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Dental caries,22558,184,1.11 [0.94-1.30],0.2231657645477929
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20005,2569,1.01 [0.97-1.06],0.6091643725005751
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23094,154,1.00 [0.83-1.20],0.9995360633105106
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of liver,23058,929,1.01 [0.94-1.09],0.8051111569943787
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20592,4603,1.01 [0.97-1.04],0.6547712465876114
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22847,473,1.03 [0.93-1.14],0.5925755996509772
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23088,513,1.02 [0.92-1.12],0.7513337339859907
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22467,93,0.89 [0.70-1.13],0.3292836166023568
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22339,60,1.10 [0.82-1.46],0.5263948275365342
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22837,1529,1.01 [0.96-1.07],0.6529647339102174
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of tongue,22357,94,1.05 [0.83-1.32],0.6850092976338333
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22448,1535,1.07 [1.01-1.13],0.023031208517502
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18408,3789,0.99 [0.96-1.03],0.6687836002596305
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,16240,251,1.01 [0.87-1.16],0.9226436852018364
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23085,205,1.02 [0.87-1.19],0.8262830738497879
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23142,28,1.49 [1.00-2.23],0.0497919907626166
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22282,153,1.01 [0.85-1.22],0.8736563513641833
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14727,108,1.10 [0.89-1.36],0.385221625442172
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,16554,565,1.01 [0.92-1.11],0.8884342198614549
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastric ulcer,16423,434,1.11 [1.00-1.24],0.0539616305487326
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18667,2678,1.00 [0.95-1.04],0.8378875340846053
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16650,661,1.07 [0.98-1.16],0.1509213824685182
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16704,8212,1.01 [0.98-1.03],0.4639817904929549
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,GI-bleeding,22578,1270,1.00 [0.94-1.07],0.9308849482839818
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22418,44,1.03 [0.74-1.45],0.8440964420781274
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15609,1182,0.94 [0.88-1.00],0.054391586695836
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22199,70,0.90 [0.69-1.19],0.4647584133638146
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Hernia,21105,3669,1.01 [0.97-1.05],0.6280442190777442
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Impacted teeth,23146,26,1.67 [1.11-2.51],0.0131839616899663
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Impaction of intestines,14698,79,0.86 [0.66-1.11],0.2487573645329263
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Inguinal hernia,18541,1105,1.00 [0.93-1.07],0.9974046502841544
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17559,123,0.97 [0.79-1.19],0.7702524286802293
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14735,116,1.06 [0.86-1.31],0.5676164773840418
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21454,146,1.07 [0.89-1.29],0.4422153724444687
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,15135,516,0.99 [0.90-1.10],0.8761841266754146
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23146,340,1.14 [1.01-1.29],0.0334392671941749
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22113,785,1.12 [1.04-1.21],0.0047800898880637
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22416,1088,1.07 [1.00-1.14],0.0628950529090858
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16208,219,0.89 [0.76-1.03],0.1223163654350261
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oesophagitis,16692,703,1.01 [0.93-1.10],0.7517500814894429
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23122,135,1.14 [0.94-1.38],0.1775936687264323
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17524,88,1.02 [0.80-1.30],0.8842767261793539
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15999,1380,1.00 [0.94-1.06],0.9112324603862536
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21279,366,1.07 [0.95-1.20],0.2592595240561146
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21060,147,1.03 [0.86-1.24],0.7285909342579135
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,16560,1941,0.98 [0.93-1.03],0.4553495136178958
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,20847,6228,0.99 [0.96-1.01],0.3080228377003585
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22317,210,1.14 [0.98-1.33],0.0811330217158552
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of liver,22900,771,1.00 [0.92-1.08],0.930193509487214
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16763,774,0.98 [0.90-1.06],0.6009264853725926
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21130,217,0.97 [0.83-1.13],0.7284873270038984
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23011,436,0.99 [0.89-1.11],0.8928503233306837
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17088,1099,1.00 [0.94-1.07],0.9141483269252196
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22595,1287,1.00 [0.94-1.07],0.9251203885706404
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22552,178,1.02 [0.86-1.21],0.7915846383181148
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16806,2187,0.99 [0.95-1.04],0.7662694527717072
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18163,2174,0.99 [0.94-1.04],0.6596208914945909
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22245,116,0.96 [0.78-1.19],0.7283903102047167
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22286,958,1.08 [1.00-1.16],0.0484632843760515
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",15070,451,0.91 [0.82-1.02],0.0968223523479336
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23138,32,1.57 [1.08-2.27],0.0179578550730252
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,15241,622,0.93 [0.85-1.02],0.122777070818426
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21466,158,1.02 [0.86-1.22],0.7936685105647998
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23167,54,0.78 [0.57-1.07],0.1221304022846519
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22368,105,0.98 [0.79-1.22],0.8530498021784906
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Toxic colitis,21409,81,0.89 [0.69-1.15],0.3794812190588357
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16336,347,1.04 [0.92-1.18],0.499608417145275
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,21498,170,1.02 [0.86-1.21],0.8036038940746222
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21463,135,0.96 [0.79-1.16],0.6706610673893019
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Umbilical hernia,17694,258,0.96 [0.83-1.10],0.554813178574451
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14868,249,0.91 [0.79-1.05],0.2139895731506733
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ventral hernia,17730,294,1.01 [0.88-1.15],0.9181999441668752
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Volvulus,14713,94,0.81 [0.64-1.03],0.0917591074138727
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23070,423,1.03 [0.93-1.15],0.5359381301222468
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22817,66,1.14 [0.87-1.50],0.3440507206617859
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20607,166,0.99 [0.84-1.18],0.9512962737116296
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22541,828,1.02 [0.94-1.10],0.6316571987226278
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21856,143,1.04 [0.86-1.26],0.6643839158083826
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21076,635,0.96 [0.88-1.06],0.4276787099531197
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22836,321,1.10 [0.97-1.25],0.1252848027303132
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23077,562,1.06 [0.97-1.17],0.200446647879268
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22561,46,1.01 [0.73-1.41],0.9410506431949148
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21565,3747,0.99 [0.96-1.03],0.7709062074332936
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22741,442,0.99 [0.89-1.10],0.7890558525150099
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22605,306,1.00 [0.88-1.14],0.990121586306846
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22793,1080,1.00 [0.93-1.07],0.9782592972712576
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23159,62,0.94 [0.71-1.26],0.6989711738927942
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20498,57,0.91 [0.67-1.23],0.540727358398511
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22363,64,0.94 [0.71-1.26],0.6939183039483945
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22823,308,1.08 [0.95-1.22],0.2502178466712343
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21047,606,0.97 [0.89-1.06],0.5268296006593969
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20531,90,0.88 [0.69-1.11],0.2831057655194979
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23090,95,0.89 [0.70-1.12],0.318109153777892
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,21955,242,1.08 [0.94-1.25],0.285028670314119
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22973,222,0.98 [0.85-1.14],0.8349016476878129
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22609,94,1.05 [0.83-1.32],0.6980820963141983
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20519,78,0.89 [0.69-1.15],0.3693638138626927
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22562,2121,1.00 [0.95-1.05],0.919266885109487
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21092,651,0.96 [0.88-1.05],0.3767681890894306
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20535,94,0.84 [0.67-1.07],0.1519826835839967
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23086,335,1.00 [0.89-1.13],0.9931993233807068
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22591,76,1.09 [0.84-1.41],0.5080192794584781
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23023,272,1.02 [0.89-1.17],0.7786828924132714
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23103,456,1.01 [0.91-1.12],0.8211473223805088
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20565,124,0.95 [0.78-1.17],0.6374642989637663
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20784,343,0.91 [0.80-1.02],0.1161671430120607
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23091,444,1.01 [0.91-1.13],0.7863321490682743
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20779,338,1.09 [0.97-1.23],0.1551159916493554
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23151,156,0.94 [0.78-1.13],0.4926305916996857
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19315,81,0.99 [0.77-1.27],0.9133697314524029
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20422,6465,1.04 [1.01-1.07],0.0100218208858144
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19012,5055,1.04 [1.01-1.08],0.0072878786985485
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19286,52,0.95 [0.70-1.31],0.7673887318172341
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19214,146,0.98 [0.81-1.18],0.817730373228253
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19263,195,1.02 [0.87-1.19],0.8360167841547023
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,22919,65,0.95 [0.72-1.26],0.7117835957290586
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",19220,152,0.98 [0.81-1.17],0.8107380455255127
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15439,1482,1.04 [0.98-1.11],0.1518557641172135
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",22966,246,1.09 [0.95-1.26],0.2228143231980036
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19655,587,1.05 [0.96-1.15],0.2821104027196873
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18747,8058,1.03 [1.00-1.06],0.0216200524306286
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20642,123,0.87 [0.70-1.06],0.1680486349631051
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,19415,181,1.00 [0.85-1.18],0.9896352151386713
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19744,510,1.01 [0.92-1.12],0.823031077403483
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22235,3167,1.02 [0.98-1.07],0.2538080247263845
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19546,312,0.84 [0.74-0.96],0.0096406189223132
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,19387,153,1.26 [1.06-1.51],0.0090850307485955
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19351,117,1.05 [0.86-1.29],0.626684751125888
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22419,104,1.01 [0.81-1.26],0.947297948513236
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15991,2034,1.05 [0.99-1.10],0.0783278817670029
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14758,801,1.14 [1.06-1.24],0.0009654105444696
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23079,794,1.13 [1.04-1.22],0.0032931833807711
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14033,76,1.26 [0.98-1.61],0.0738051551184595
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14262,305,1.02 [0.90-1.16],0.7221795134723002
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19498,264,1.02 [0.89-1.17],0.7690835715690292
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14442,485,1.02 [0.92-1.13],0.7420155025293209
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,19150,82,1.37 [1.08-1.73],0.0100749311361371
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19757,689,1.05 [0.96-1.14],0.2720119371554182
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19386,318,1.10 [0.97-1.24],0.1444835571092031
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14412,455,1.02 [0.91-1.13],0.7668859360681106
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19305,71,1.13 [0.87-1.47],0.3673839549034964
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19294,60,1.15 [0.87-1.53],0.3334484391443728
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20606,87,1.01 [0.80-1.29],0.9052641090947888
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22748,2229,0.98 [0.94-1.03],0.4383322568332196
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22079,1560,0.98 [0.92-1.03],0.4198441928799792
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23010,537,1.09 [0.99-1.20],0.0841052188923699
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,17105,3148,1.06 [1.02-1.10],0.0033439036354132
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14000,43,0.82 [0.57-1.16],0.2548931909358504
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19341,107,1.25 [1.01-1.55],0.0387303049012602
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14029,72,1.05 [0.81-1.38],0.6974182043825536
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14094,137,1.08 [0.89-1.30],0.4483684804221948
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20759,240,0.96 [0.83-1.12],0.6171534757334316
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21030,511,0.99 [0.89-1.09],0.7873533448396912
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23155,111,1.11 [0.90-1.37],0.3369974086825739
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21071,2003,1.03 [0.98-1.08],0.2521712760689408
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19313,79,1.26 [0.98-1.61],0.0677965064153442
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14113,156,1.07 [0.89-1.28],0.4583231276907195
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19870,802,1.08 [0.99-1.16],0.0675375964204273
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,16153,2196,1.04 [0.99-1.09],0.1393628435164126
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22446,131,1.03 [0.85-1.25],0.7659214665795518
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23168,63,1.19 [0.90-1.57],0.2248066515370524
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19311,77,1.00 [0.77-1.30],0.9885551567542016
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20596,1362,1.09 [1.03-1.16],0.0051656372676425
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19339,105,1.01 [0.81-1.26],0.9145289632212072
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16050,2093,1.04 [0.99-1.10],0.084654293641735
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20634,115,0.92 [0.75-1.14],0.4544218124882481
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19272,38,0.90 [0.62-1.30],0.571994280498364
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,19265,197,0.88 [0.75-1.03],0.1196481320433316
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19926,692,1.05 [0.96-1.14],0.2725251854396472
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22812,497,1.12 [1.02-1.24],0.0218359501199796
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19732,664,1.02 [0.94-1.12],0.6253092999492231
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23024,530,1.08 [0.98-1.19],0.0992583036679261
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23152,69,1.34 [1.04-1.74],0.0258231921989582
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19400,166,0.83 [0.69-0.99],0.0398235454356095
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18001,886,1.02 [0.95-1.11],0.5261580677455311
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19882,648,1.08 [0.99-1.18],0.0859640196431087
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19514,280,0.84 [0.73-0.96],0.011181730703263
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14027,70,1.14 [0.87-1.48],0.337210535995728
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,17100,3143,1.07 [1.02-1.11],0.0015372381421025
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14806,849,1.06 [0.98-1.15],0.1223591464646791
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22694,379,1.09 [0.97-1.22],0.1490216692651324
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23124,80,0.98 [0.76-1.27],0.8995699678014224
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20493,71,1.07 [0.82-1.40],0.6256895849297154
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14021,64,1.19 [0.90-1.56],0.2205865570914218
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,19175,107,1.09 [0.88-1.35],0.4197443175179366
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14501,544,1.10 [1.00-1.21],0.0506582425466227
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19568,334,1.05 [0.92-1.18],0.4747783183696334
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19357,289,1.18 [1.04-1.34],0.0129729184721169
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,19335,267,1.05 [0.92-1.21],0.4693672235707458
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16255,66,1.33 [1.02-1.74],0.0337193712529826
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23157,74,1.26 [0.98-1.62],0.0770043915381139
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19784,550,1.04 [0.95-1.15],0.4156407420642832
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22409,94,1.21 [0.97-1.52],0.0927181883086894
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21883,2649,1.05 [1.00-1.09],0.0373813130346647
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19384,150,1.01 [0.84-1.22],0.8953327734890297
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19793,725,1.06 [0.98-1.16],0.1417782358602302
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21804,275,0.86 [0.74-0.98],0.0271136471031862
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,19325,257,1.01 [0.88-1.16],0.8775382937318138
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21093,2025,1.03 [0.98-1.08],0.26480097886077
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20387,1319,1.05 [0.99-1.11],0.1377482345390955
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19298,64,1.19 [0.90-1.57],0.2147644075468091
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22435,120,1.02 [0.83-1.25],0.8723650951501951
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19396,162,1.13 [0.95-1.35],0.1591114121535215
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,19325,91,0.96 [0.76-1.22],0.7422178968748001
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14034,77,1.11 [0.86-1.43],0.4300973413499462
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21653,2263,1.04 [0.99-1.09],0.0846663173838342
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9287,26,1.34 [0.88-2.05],0.1784121436573793
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11781,34,1.11 [0.76-1.62],0.6006741093932944
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22846,312,1.12 [0.99-1.27],0.080370416656062
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22638,104,0.99 [0.79-1.24],0.9243153901372352
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21741,2351,1.03 [0.98-1.08],0.1965605139507461
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,22945,132,1.14 [0.94-1.38],0.1973030135454108
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,22865,408,1.01 [0.91-1.13],0.8009130160973754
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Cystitis,19311,303,1.06 [0.93-1.20],0.3969402485822019
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Dialysis,19486,96,1.29 [1.03-1.61],0.0283758596950423
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10210,2140,1.01 [0.96-1.06],0.7300143983073507
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11882,135,1.14 [0.94-1.38],0.1778951789340583
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9301,40,1.21 [0.85-1.71],0.2922582760095414
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9841,580,1.00 [0.91-1.10],0.9584099431765036
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19080,6302,1.01 [0.98-1.04],0.596252858787917
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,22912,99,1.03 [0.82-1.30],0.7667621785029188
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,8188,118,0.86 [0.69-1.06],0.1511585503766396
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19461,353,1.04 [0.92-1.17],0.5430157037949277
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9888,1818,1.00 [0.95-1.05],0.9623990150318787
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11944,161,1.04 [0.87-1.24],0.6447437823738498
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8198,128,0.91 [0.74-1.12],0.3671269244380735
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,19098,90,1.08 [0.85-1.37],0.5188109804535328
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10288,1027,0.97 [0.90-1.04],0.3887478580075545
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,8130,60,0.85 [0.63-1.15],0.2949078411731688
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9301,40,0.76 [0.52-1.10],0.1398165300256143
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23164,89,1.04 [0.82-1.32],0.7437063290263981
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23166,86,0.86 [0.67-1.10],0.2160929302635355
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21970,2962,1.00 [0.95-1.04],0.829301982607937
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19956,948,0.96 [0.89-1.03],0.2530864340321359
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11797,50,1.15 [0.84-1.57],0.385070958053074
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23090,633,1.02 [0.93-1.12],0.6498544564234282
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8223,153,1.06 [0.88-1.27],0.5580433769763238
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8234,164,1.08 [0.90-1.28],0.4010332753994736
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8224,154,0.89 [0.74-1.07],0.2086077527491352
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23136,87,0.98 [0.77-1.24],0.8406488170395934
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21360,2352,1.02 [0.97-1.06],0.5141970754840206
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11867,84,1.01 [0.79-1.30],0.91428104567352
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9327,66,1.23 [0.94-1.61],0.1357797788709648
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9400,139,0.92 [0.76-1.11],0.3755991135963438
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9314,53,0.84 [0.61-1.15],0.2776435971806751
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9362,101,0.92 [0.74-1.16],0.4978770335187307
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19522,414,1.04 [0.93-1.16],0.5041605534721539
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22659,202,1.03 [0.88-1.21],0.6890467136418941
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9385,124,1.01 [0.83-1.24],0.9123766993904436
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9286,25,0.82 [0.51-1.30],0.3895291988407795
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9471,210,1.01 [0.86-1.18],0.9296732035478948
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9354,93,1.11 [0.88-1.39],0.3841805364028745
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9468,207,0.95 [0.81-1.11],0.4980561563681897
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,22860,47,0.90 [0.65-1.26],0.5469284298054965
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8224,154,0.95 [0.79-1.14],0.5509607680294268
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22885,3777,1.03 [0.99-1.07],0.1084183290896335
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",19200,92,1.03 [0.82-1.31],0.7806880526767072
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19575,185,1.00 [0.85-1.18],0.9839419702524386
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22571,37,0.90 [0.62-1.31],0.5699566892607046
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19280,272,0.99 [0.86-1.14],0.9017155656134876
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22930,396,1.08 [0.97-1.21],0.1791437615564516
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9297,36,1.01 [0.69-1.47],0.9706231472152054
